Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clusterin-like protein 1 (CLUL1) is a retina-specific, secreted glycoprotein with homology to the molecular chaperone clusterin, though sharing only ~25% sequence identity. Unlike clusterin, which has broad tissue expression, CLUL1 expression is tentative to cone photoreceptor cells in the retina and is highly regulated during retinal development and photoreceptor differentiation. It undergoes light-dependent subcellular localization in cone cells and is predicted to bind misfolded proteins and function as an extracellular chaperone, supporting photoreceptor cell homeostasis and survival. Genetic studies have associated CLUL1 with retinal diseases—variants may influence susceptibility or protection against age-related macular degeneration (AMD), though clearly pathogenic or drug-responsive mutations in humans are not established. Its relevance to retinal disorders is further supported by altered expression in naturally occurring and experimental animal models of retinal degeneration. Peptides derived from CLUL1 have been proposed as potential biomarkers for diagnosing retinal and possibly systemic disease states, but these applications remain under investigation. CLUL1 is not a classic drug target, and no current therapeutics directly modulate its function. Its main significance lies in its putative role as a retinal photoreceptor chaperone and as a gene of interest in genetic association studies of retinal diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clusterin-like protein 1 (CLUL1).